CGON
CG Oncology, Inc. Common stock
NASDAQ · USHealthcareBiotechnology
$70.19-2.31%
Price as of Jul 20, 2026
CGON valuation
CG Oncology, Inc. Common stock valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 155.05x
- P/S forward
- 113.45x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.67x
- Price / sales
- 1220.85x
- Price / cash flow
- -38.69x
Enterprise value
- Enterprise value
- $5.1B
- EV / sales
- 1010.11x
- EV / EBITDA
- -27.77x
- EV / EBIT
- -23.83x
- Market cap
- $6.2B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.